Genetic Analysis of Seven Pateints with Hereditary Multiple Osteochondromas (HMO)

Overview

Journal Am J Transl Res

Specialty General Medicine

Date 2022 Oct 17

PMID 36247276

Authors

Zhuo Ren

Jia-Yu Yuan

Jing Zhang

Ya Tan

Wen-Qi Chen

Zhen-Tao Zhang

Ya-Zhou Li

Affiliations

Soon will be listed here.

Abstract

Background: HMO (Hereditary Multiple Osteochondroma), an uncommon autosomal dominant disorder, is characterized by the development of multiple osteochondromas, which are nonmalignant cartilage-capped bone tumors growing outwards from long bone metaphyses.

Methods: The present work retrospectively analyzed seven children with HMO who were enrolled for routine clinical diagnosis and treatment, including X-ray examination. Subsequent genetic detection was carried out using whole exome sequencing (WES). In addition, this work applied Sanger sequencing to be the validation approach. Moreover, this work also examined amino acid (AA) evolutionary conservatism under the influence of certain missense variants.

Results: The clinical indications of all seven patients and their family members were thoroughly indexed. WES identified diagnostic variants in the or gene in these patients. In these variants, four were reported for the first time, namely : c.1285-2A>T, : c.1139delT, : c.203G>A, and : c.1645_1673del. Familial validation revealed that three of the variants were hereditary, while the other four were , which was consistent with the phenotype in each case.

Conclusion: Our results expanded HMO variation spectrum, and laid certain foundations for the precise counseling of those affected families.

Citing Articles

Osteochondroma of the Rib: A Potentially Life-Threatening Benign Tumor.

Morales L, Cardona Ortegon J, Pinzon Valderrama B, Jimenez Uribe A, Mora Bendeck N, Fierro Avila F Cureus. 2023; 15(9):e45449.

PMID: 37859900 PMC: 10583481. DOI: 10.7759/cureus.45449.

References

Mordenti M, Ferrari E, Pedrini E, Fabbri N, Campanacci L, Muselli M . Validation of a new multiple osteochondromas classification through Switching Neural Networks. Am J Med Genet A. 2013; 161A(3):556-60. DOI: 10.1002/ajmg.a.35819. View

Zhang J, Hu H, Mu W, Yu M, Chen W, Mi D . Case Report: Exome Sequencing Identified a Novel Compound Heterozygous Variation in Causing Bruck Syndrome Type 2. Front Genet. 2021; 12:619948. PMC: 7921790. DOI: 10.3389/fgene.2021.619948. View

Ryckx A, Somers J, Allaert L . Hereditary multiple exostosis. Acta Orthop Belg. 2014; 79(6):597-607. View

Hennekam R . Hereditary multiple exostoses. J Med Genet. 1991; 28(4):262-6. PMC: 1016830. DOI: 10.1136/jmg.28.4.262. View

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J . Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015; 17(5):405-24. PMC: 4544753. DOI: 10.1038/gim.2015.30. View

Yang K, Shen M, Yan Y, Tan Y, Zhang J, Wu J . Genetic Analysis in Fetal Skeletal Dysplasias by Trio Whole-Exome Sequencing. Biomed Res Int. 2019; 2019:2492590. PMC: 6537022. DOI: 10.1155/2019/2492590. View

Sarrazin S, Lamanna W, Esko J . Heparan sulfate proteoglycans. Cold Spring Harb Perspect Biol. 2011; 3(7). PMC: 3119907. DOI: 10.1101/cshperspect.a004952. View

Heinritz W, Huffmeier U, Strenge S, Miterski B, Zweier C, Leinung S . New mutations of EXT1 and EXT2 genes in German patients with Multiple Osteochondromas. Ann Hum Genet. 2009; 73(Pt 3):283-91. DOI: 10.1111/j.1469-1809.2009.00508.x. View

Xu D, Esko J . Demystifying heparan sulfate-protein interactions. Annu Rev Biochem. 2014; 83:129-57. PMC: 7851832. DOI: 10.1146/annurev-biochem-060713-035314. View

10.

Huang Y, Gao C, Zheng C, Chen X, Yan Y, Sun Y . Investigation of a Novel Variant Causing Autosomal-Dominant Tooth Agenesis. Front Genet. 2021; 12:688241. PMC: 8292820. DOI: 10.3389/fgene.2021.688241. View

11.

Huegel J, Sgariglia F, Enomoto-Iwamoto M, Koyama E, Dormans J, Pacifici M . Heparan sulfate in skeletal development, growth, and pathology: the case of hereditary multiple exostoses. Dev Dyn. 2013; 242(9):1021-32. PMC: 4007065. DOI: 10.1002/dvdy.24010. View

12.

Wells D, Hill A, Lin X, Ahn J, Brown N, Wagner M . Identification of novel mutations in the human EXT1 tumor suppressor gene. Hum Genet. 1997; 99(5):612-5. DOI: 10.1007/s004390050415. View

13.

Mundy C, Bello A, Sgariglia F, Koyama E, Pacifici M . HhAntag, a Hedgehog Signaling Antagonist, Suppresses Chondrogenesis and Modulates Canonical and Non-Canonical BMP Signaling. J Cell Physiol. 2015; 231(5):1033-44. DOI: 10.1002/jcp.25192. View

14.

Li Y, Wang J, Wang Z, Tang J, Yu T . A genotype-phenotype study of hereditary multiple exostoses in forty-six Chinese patients. BMC Med Genet. 2017; 18(1):126. PMC: 5681804. DOI: 10.1186/s12881-017-0488-2. View

15.

Gentile M, Agolini E, Cocciadiferro D, Ficarella R, Ponzi E, Bellacchio E . Novel exostosin-2 missense variants in a family with autosomal recessive exostosin-2-related syndrome: further evidences on the phenotype. Clin Genet. 2018; 95(1):165-171. DOI: 10.1111/cge.13458. View

16.

Xian C, Zhu M, Nong T, Li Y, Xie X, Li X . A novel mutation in ext2 caused hereditary multiple exostoses through reducing the synthesis of heparan sulfate. Genet Mol Biol. 2021; 44(2):e20200334. PMC: 8156126. DOI: 10.1590/1678-4685-GMB-2020-0334. View

17.

Alvarez C, Tredwell S, De Vera M, Hayden M . The genotype-phenotype correlation of hereditary multiple exostoses. Clin Genet. 2006; 70(2):122-30. DOI: 10.1111/j.1399-0004.2006.00653.x. View

18.

Billings P, Pacifici M . Interactions of signaling proteins, growth factors and other proteins with heparan sulfate: mechanisms and mysteries. Connect Tissue Res. 2015; 56(4):272-80. PMC: 4785798. DOI: 10.3109/03008207.2015.1045066. View

19.

DArienzo A, Andreani L, Sacchetti F, Colangeli S, Capanna R . Hereditary Multiple Exostoses: Current Insights. Orthop Res Rev. 2019; 11:199-211. PMC: 6916679. DOI: 10.2147/ORR.S183979. View

20.

Le Merrer M, Legeai-Mallet L, Jeannin P, Horsthemke B, Schinzel A, Plauchu H . A gene for hereditary multiple exostoses maps to chromosome 19p. Hum Mol Genet. 1994; 3(5):717-22. DOI: 10.1093/hmg/3.5.717. View